Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
26.02
-0.08 (-0.31%)
At close: Oct 21, 2026, 4:00 PM EDT
25.40
-0.62 (-2.38%)
After-hours: Oct 21, 2026, 7:34 PM EDT
Nurix Therapeutics Market Cap
Nurix Therapeutics has a market cap or net worth of $2.84 billion as of October 21, 2026. It is the 5,333rd most valuable company in the world and the 1,538th biggest in the United States. Its market cap has increased by 255.86% in one year.
Market Cap
2.84B
Enterprise Value
1.86B
1-Year Change
255.86%
Global Rank
Country Rank
#1,538 United States
Category
ChartMarket Cap Chart
Since July 24, 2020, Nurix Therapeutics's market cap has increased from $704.09M to $2.84B, an increase of 303.74%. That is a compound annual growth rate of 25.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 2.84B | 47.83% |
| Dec 31, 2025 | 1.92B | 44.09% |
| Dec 31, 2024 | 1.33B | 166.61% |
| Dec 29, 2023 | 500.56M | -3.31% |
| Dec 30, 2022 | 517.68M | -59.92% |
| Dec 31, 2021 | 1.29B | 1.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Disc Medicine | 3.03B |
| Viking Therapeutics | 2.92B |
| Denali Therapeutics | 2.88B |
| Dyne Therapeutics | 2.84B |
| Enliven Therapeutics | 2.84B |
| Arcus Biosciences | 2.82B |
| Celcuity | 2.79B |
| Zai Lab | 2.70B |